Steroid Hormone Interactions with Target Cells: Cross Talk between Membrane and Nuclear Pathways

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 3, 2003, Pages 839-845

  Farach Carson, Mary C ^a   Davis, Paul J ^b  

^a UNIVERSITY OF DELAWARE   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; STEROID HORMONE; STEROID RECEPTOR; THYROID HORMONE RECEPTOR; VITAMIN D RECEPTOR;

CARDIOVASCULAR SYSTEM; CELL FRACTIONATION; CELL FUNCTION; CELL MEMBRANE; CELL NUCLEUS; GENETIC TRANSCRIPTION; GENITAL SYSTEM; HORMONE ACTION; HUMAN; MAMMARY GLAND; MOLECULAR BIOLOGY; NERVOUS SYSTEM; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SKELETON; TARGET CELL;

ANIMALS; CALCITRIOL; CELL MEMBRANE; CELL NUCLEUS; ESTROGENS; HORMONES; HUMANS; RECEPTOR CROSS-TALK; STEROIDS; THYROID HORMONES;

EID: 0345599864     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.055038     Document Type: Review

References (51)

1. Barsony J and Prufer K (2002) Vitamin D receptor and retinoid X receptor interactions in motion. Vitam Horm 65:345-376.
2. 3 stimulates phosphorylation of IκBa and synergizes with TPA to induce nuclear translocation of NFκB during monocytic differentiation of NB4 leukemia cells. Exp Cell Res 272:176-184.
3. 3 involves cell-maturation-specfiic membrane-receptor-activated phospholipids metabolism. Crit Rev Oral Biol Med 13:143-154.
4. Brown AJ (2001) Therapeutic uses of vitamin D analogues. Am J Kidney Dis 38:S3-S19.
5. 3. Activation of muscle cell PLC γ through the tyrosine kinase c-Src and PtdIns 3-kinase. Eur J Biochem 269:2506-2515.
6. Carey M (1998) The enhanceosome and transcriptional synergy. Cell 92:5-8.
7. Chambliss KL and Shaul PW (2002) Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 23:665-686.
8. Davis P and Davis F (2002) Nongenomic actions of thyroid hormone, in Contemporary Endocrinology: Diseases of the Thyroid (Le B ed) pp 19-37, Humana Press, Totowa, NJ.
9. Davis PJ, Shih A, Lin HY, Martino LJ, and Davis FB (2000) Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. J Biol Chem 275:38032-38039.
10. Erben RG, Soegiarto DW, Weber K, Zeitz U, Lieberherr M, Gniadecki R, Moller G, Adamski J, and Balling R (2002) Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol 16:1524-1537.
11. Falkenstein E, Tillmann HC, Christ M, Feuring M, and Wehling M (2000) Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacol Rev 52:513-556.
12. Farach-Carson MC and Nemere I (2003) Membrane receptors for vitamin D steroid hormones: potential new drug targets. Curr Drug Targets 4:67-76.
13. 2+ influx-activating analog in osteoblastic ROS 17/2.8 cells. Steroids 67:467-470.
14. Figtree GA, McDonald D, Watkins H, and Channon KM (2003) Truncated estrogen receptor α 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation 107:120-126.
15. Gniadecki R (1998) Nongenomic signaling by vitamin D: a new face of Src. Biochem Pharmacol 56:1273-1277.
16. 3. Crit Rev Eukaryotic Gene Expression 11:299-317.
17. Hewitt SC and Korach KS (2003) Oestrogen receptor knockout mice: roles for oestrogen receptors α and β in reproductive tissues. Reproduction 125:143-149.
18. Incerpi S, Luly P, De Vito P, and Farias RN (1999) Short-term effects of thyroid hormones on the Na/H antiport in L-6 myoblasts: high molecular specificity for 3,3′,5-triiodo-L-thyronine. Endocrinology 140:683-689.
19. Kelly MJ, Qiu J, Wagner EJ, and Ronnekleiv OK (2002) Rapid effects of estrogen on G protein-coupled receptor activation of potassium channels in the central nervous system (CNS). J Steroid Biochem Mol Biol 83:187-193.
20. Li L, Haynes MP, and Bender JR (2003) Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 100:4807-4812.
21. Lin HY, Davis FB, Gordinier JK, Martino LJ, and Davis PJ (1999) Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. Am J Physiol 276:C1014-C1024.
22. Lin H-Y, Zhang S, West B, Tang H-Y, Passaretti T, Davis F, and Davis P (2003) Identification of the putative MAP kinase docking site in the thyroid hormone receptor-β1 DNA-binding domain: functional consequences of mutations at the docking site. Biochemistry 42:7571-7579.
23. 2+. Biochem Biophys Res Commun 273:95-100.
24. MacDonald PN, Baudino TA, Tokumaru H, Dowd DR, and Zhang C (2001) Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription. Steroids 66:171-176.
25. Manolagas SC, Kousteni S, and Jilka RL (2002) Sex steroids and bone. Recent Prog Horm Res 57:385-409.
26. Marquez DC, Lee J, Lin T, and Pietras RJ (2001) Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor. Endocrine 16:73-81.
27. Meegan MJ and Lloyd DG (2003) Advances in the science of estrogen receptor modulation. Curr Med Chem 10:181-210.
28. Mendelsohn ME (2002) Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 90:3F-6F.
29. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Bottero D, Varricchio L, Nanayakkara M, Rotondi A, and Auricchio F (2002) Sex steroid hormones act as growth factors. J Steroid Biochem Mol Biol 83:31-35.
30. Miller LD, Park KS, Guo QM, Alkharouf NW, Malek PL, Lee NH, Liu ET, and Cheng SY (2001) Silencing of Wnt signaling and activation of multiple metabolic pathways in response to thyroid hormone-stimulated cell proliferation. Mol Cell Biol 21:6626-6639.
31. Moggs JG, Deavall DG, and Orphanides G (2003) Sex steroids, ANGELS and osteoporosis. Bioessays 25:195-199.
32. Nemere I, Pietras RJ, and Blackmore PF (2003) Membrane receptors for steroid hormones: signal transduction and physiological significance. J Cell Biochem 88:438-445.
33. Norman AW, Ishizuka S, and Okamura WH (2001) Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein. J Steroid Biochem Mol Biol 76:49-59.
34. Pedram A, Razandi M, Aitkenhead M, Hughes CC, and Levin ER (2002) Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem 277:50768-50775.
35. Pike JW, Yamamoto H, and Shevde NK (2002) Vitamin D receptor-mediated gene regulation mechanisms and current concepts of vitamin D analog selectivity. Adv Ren Replace Ther 9:168-174.
36. Ratajczak T (2001) Protein coregulators that mediate estrogen receptor function. Reprod Fertil Dev 13:221-229.
37. Razandi M, Alton G, Pedram A, Ghonshani S, Webb P, and Levin ER (2003) Identification of a structural determinant necessary for the localization and function of estrogen receptor α at the plasma membrane. Mol Cell Biol 23:1633-1646.
38. Schmidt BM, Martin N, Georgens AC, Tillmann HC, Feuring M, Christ M, and Wehling M (2002) Nongenomic cardiovascular effects of triiodothyronine in euthyroid male volunteers. J Clin Endocrinol Metab 87:1681-1686.
39. Shih A, Lin HY, Davis FB, and Davis PJ (2001) Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry 40:2870-2878.
40. Siegrist-Kaiser CA, Juge-Aubry C, Tranter MP, Ekenbarger DM, and Leonard JL (1990) Thyroxine-dependent modulation of actin polymerization in cultured astrocytes. A novel, extranuclear action of thyroid hormone. J Biol Chem 265:5296-5302.
41. Singh S, Shaul PW, and Gupta PD (2002) Conventional estrogen receptors are found in the plasma membrane of vaginal epithelial cells of the rat. Steroids 67:757-764.
42. Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, Singh M, Connolly ES Jr, Nethrapalli IS, and Tinnikov AA (2002) ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci 22:8391-8401.
43. Vasudevan N, Ogawa S, and Pfaff D (2002) Estrogen and thyroid hormone receptor interactions: Physiological flexibility by molecular specificity. Physiol Rev 82:923-944.
44. 3 to increase intracellular calcium and activate protein kinase C in mouse osteoblasts. J Cell Biochem 88:794-801.
45. Watanabe H, Suzuki A, Mizutani T, Khono S, Lubahn DB, Handa H, and Iguchi T (2002) Genome-wide analysis of changes in early gene expression induced by oestrogen. Genes Cells 7:497-507.
46. 3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J Steroid Biochem Mol Biol 83:85-92.
47. Wiebe JP (1997) Nongenomic actions of steroids on gonadotropin release. Recent Prog Horm Res 52:71-99; Discussion 99-101.
48. Wrutniak-Cabello CCF, Grandemange S, Seyer P, Busson M, Carazo A, and Cabello G (2002) Study of thyroid hormone action on mitochondria opens up a new field of reserach: mitochondrial endocrinology. Curr Opin Endocrinol Diabetes 9:387-392.
49. Yen PM (2001) Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142.
50. Zhu W and Smart EJ (2003) Caveolae, estrogen and nitric oxide. Trends Endocrinol Metab 14:114-117.
51. Zhu XG, Hanover JA, Hager GL, and Cheng SY (1998) Hormone-induced translocation of thyroid hormone receptors in living cells visualized using a receptor green fluorescent protein chimera. J Biol Chem 273:27058-27063.